From: ER stress induced immunopathology involving complement in CADASIL: implications for therapeutics
Parameter | Controls (Age-matched) | CADASIL | Old Controls | SVD‖ |
---|---|---|---|---|
n (total = 55) | 11 | 16 | 10 | 10 |
Mean age (years) | 57.5 | 59.0 | 83.4 | 81.0 |
Range (years) | 49–69 | 33–74 | 78–94 | 67–96 |
Gender (M/F) | 6/5 | 10/6 | 2/8 | 5/5 |
Mean age at onset (years) | - | 46.9 | - | n/a |
Duration of Disease (years) | - | 12.6 | - | n/a |
Key disease features | . | Migraine, TIA, lacunar strokes, cognitive impairment | - | White matter disease, lacunar strokes, dementia |
NOTCH3 Mutations | - | Arg133Cys (6); Arg141Cys (2); Arg153Cys (2); Arg169Cys (3); Cys445Arg (1); Arg558Cys (1); Arg985Cys (1) | - | - |
Cause(s) of death | Cardiac arrest, cancer, renal failure, infection | Bronchopneumonia, heart failure | Heart failure, cancer, ischemic bowel infection. | Heart failure, Cancer, GI bleed, sudden death |
Neuropathological Features | ||||
Braak stage | 0 | 0 | 0-IV | 1–4 |
CERAD score | 1 | 0 | 2 | 0–2 |
Median Vascular Pathology score /10 | 3 | 9 | 5.5 | 6 |
Mean Sclerotic Index | 0.28 | 0.36 | 0.27 | 0.30 |